It is also known that BAFF activates B cells through the NF-κB signaling pathway in patients with IgA nephropathy [40] and that B cell activation and elevated BAFF levels are present in these patients [41,42]. This evidence concerns the gene NFKB1 and IgA glomerulonephritis.